Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells

Stem Cells and Development

Volumn 22, Issue 10, 2013, Pages 1614-1623

  Hsiao, Sarah T ^a,b   Lokmic, Zerina ^a,b   Peshavariya, Hitesh ^a,b   Abberton, Keren M ^a,b,c   Dusting, Gregory J ^a,b   Lim, Shiang Y ^a,b   Dilley, Rodney J ^a,b,d  

^a O'Brien Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; POLYVINYL ALCOHOL SPONGE; VASCULOTROPIN A; VASCULOTROPIN D;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHANGIOGENESIS; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; STIMULUS;

ADIPOSE TISSUE; ANIMALS; CELL HYPOXIA; CULTURE MEDIA, CONDITIONED; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PARACRINE COMMUNICATION; RIBONUCLEASE, PANCREATIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84877355288     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0602     Document Type: Article

References (45)

1. Barry FP, JM Murphy. (2004). Mesenchymal stem cells: clinical applications, biological characterization. Int J Biochem Cell Biol 36:568-584
2. Rastegar F, D Shenaq, J Huang,WZhang, BQ Zhang, BC He, L Chen, GW Zuo, Q Luo, et al. (2010). Mesenchymal stem cells: molecular characteristics, clinical applications. World J Stem Cells 2:67-80
3. Mirotsou M, TM Jayawardena, J Schmeckpeper, M Gnecchi, VJ Dzau. (2011). Paracrine mechanisms of stem cell reparative, regenerative actions in the heart. J Mol Cell Cardiol 50:280-289
4. Williams AR, JM Hare. (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings,, therapeutic implications for cardiac disease. Circ Res 109:923-940
5. Zhang M, N Mal, M Kiedrowski, M Chacko, AT Askari, ZB Popovic, ON Koc, MS Penn. (2007). SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21:3197-3207
6. Deuse T, C Peter, PW Fedak, T Doyle, H Reichenspurner, WH Zimmermann, T Eschenhagen, W Stein, JC Wu, RC Robbins, S Schrepfer. (2009). Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120:S247-254
7. Chen SL, CC Zhu, YQ Liu, LJ Tang, L Yi, BJ Yu, DJ Wang. (2009). Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. J Int Med Res 37:68-78
8. Huang SD, FL Lu, XY Xu, XH Liu, XX Zhao, BZ Zhao, L Wang, DJ Gong, Y Yuan, ZY Xu. (2006). Transplantation of angiogenin-overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia. J Thorac Cardiovasc Surg 132:1329-1338
9. Gnecchi M, H He, OD Liang, LG Melo, F Morello, H Mu, N Noiseux, L Zhang, RE Pratt, JS Ingwall, VJ Dzau. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368
10. Li H, S Zuo, Z He, Y Yang, Z Pasha, Y Wang, M Xu. (2010). Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis, cell survival. Am J Physiol Heart Circ Physiol 299:H1772-H1781
11. Murry CE, RB Jennings, KA Reimer. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
12. Lim SY, RJ Dilley, GJ Dusting. (2011). Cytoprotection, preconditioning for stem cell therapy. In Advances in Regenerative Medicine. InTech, pp 89-118
13. Hu X, SP Yu, JL Fraser, Z Lu, ME Ogle, JA Wang, L Wei. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells, angiogenesis. J Thorac Cardiovasc Surg 135:799-808
14. Rehman J, D Traktuev, J Li, S Merfeld-Clauss, CJ Temm-Grove, JE Bovenkerk, CL Pell, BH Johnstone, RV Considine, KL March. (2004). Secretion of angiogenic, antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298
15. Hsiao ST, A Asgari, Z Lokmic, R Sinclair, GJ Dusting, SY Lim, RJ Dilley. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose,, dermal tissue. Stem Cells Dev 21:2189-2203
16. Stubbs SL, ST Hsiao, HM Peshavariya, SY Lim, GJ Dusting, RJ Dilley. (2012). Hypoxic preconditioning enhances survival of human adipose-derived stem cells, conditions endothelial cells in vitro. Stem Cells Dev 21:2189-2203
17. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim, MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295
18. Hague S, IZ MacKenzie, R Bicknell, MC Rees. (2002). Invivo angiogenesis, progestogens. Hum Reprod 17:786-793
19. Wei X, Z Du, L Zhao, D Feng, G Wei, Y He, J Tan, WH Lee, H Hampel, et al. (2009). IFATS collection: the conditioned media of adipose stromal cells protect against hypoxiaischemia-induced brain damage in neonatal rats. Stem Cells 27:478-488
20. Timmers L, SK Lim, IE Hoefer, F Arslan, RC Lai, AA van Oorschot, MJ Goumans, C Strijder, SK Sze, et al. (2011). Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6:206-214
21. Li L, S Zhang, Y Zhang, B Yu, Y Xu, Z Guan. (2009). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36:725-731
22. Hockel M, P Vaupel. (2001). Tumor hypoxia: definitions, current clinical, biologic,, molecular aspects. J Natl Cancer Inst 93:266-276
23. Acker T, J Fandrey, H Acker. (2006). The good, the bad, the ugly in oxygen-sensing: ROS, cytochromes, prolyl-hydroxylases. Cardiovasc Res 71:195-207
24. Kemp PJ. (2006). Detecting acute changes in oxygen: will the real sensor please stand up? Exp Physiol 91:829-834
25. Hool LC. (2005). Acute hypoxia differentially regulates K( + ) channels. Implications with respect to cardiac arrhythmia. Eur Biophys J 34:369-376
26. Kim JH, SH Park, SG Park, JS Choi, Y Xia, JH Sung. (2011). The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells. Stem Cells Dev 20:1753-1761
27. Kim JH, SY Song, SG Park, SU Song, Y Xia, JH Sung. (2012). Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells. Stem Cells Dev 21:2212-2221
28. Liu Y, SR Cox, T Morita, S Kourembanas. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5 enhancer. Circ Res 77:638-643
29. Hartmann A, M Kunz, S Kostlin, R Gillitzer, A Toksoy, EB Brocker, CE Klein. (1999). Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 59:1578-1583
30. Kishimoto K, S Liu, T Tsuji, KA Olson, GF Hu. (2005). Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation, angiogenesis. Oncogene 24:445-456
31. Pilch H, K Schlenger, E Steiner, P Brockerhoff, P Knapstein, P Vaupel. (2001). Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells, cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11:137-142
32. Nakamura M, H Yamabe, H Osawa, N Nakamura, M Shimada, R Kumasaka, R Murakami, T Fujita, T Osanai, K Okumura. (2006). Hypoxic conditions stimulate the production of angiogenin, vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant 21:1489-1495
33. Hao X, A Mansson-Broberg, KH Grinnemo, AJ Siddiqui, G Dellgren, LA Brodin, C Sylven. (2007). Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Cardiovasc Res 73:481-487
34. Lee RJ, ML Springer, WE Blanco-Bose, R Shaw, PC Ursell, HM Blau. (2000). VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901
35. Saxena SK, SM Rybak, RT Davey, Jr., RJ Youle, EJ Ackerman. (1992). Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. J Biol Chem 267:21982-21986
36. Hu GF, DJ Strydom, JW Fett, JF Riordan, BL Vallee. (1993). Actin is a binding protein for angiogenin. Proc Natl Acad Sci U S A 90:1217-1221
37. Moroianu J, JF Riordan. (1994). Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A 91:1677-1681
38. Liu XH, CG Bai, ZY Xu, SD Huang, Y Yuan, DJ Gong, JR Zhang. (2008). Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia, enhances vasculogenesis in myocardial infarction. Microvasc Res 76:23-30
39. Kim WS, BS Park, JH Sung, JM Yang, SB Park, SJ Kwak, JS Park. (2007). Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 48:15-24
40. Kim WS, BS Park, JH Sung. (2009). The wound-healing, antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 9:879-887
41. Karkkainen MJ, L Jussila, RE Ferrell, DN Finegold, K Alitalo. (2001). Molecular regulation of lymphangiogenesis, targets for tissue oedema. Trends Mol Med 7:18-22
42. Kataru RP, K Jung, C Jang, H Yang, RA Schwendener, JE Baik, SH Han, K Alitalo, GY Koh. (2009). Critical role of CD11b + macrophages, VEGF in inflammatory lymphangiogenesis, antigen clearance,, inflammation resolution. Blood 113:5650-5659
43. Shimamura K, T Nakatani, A Ueda, J Sugama, M Okuwa. (2009). Relationship between lymphangiogenesis, exudates during the wound-healing process of mouse skin full-thickness wound. Wound Repair Regen 17:598-605
44. Conrad C, H Niess, R Huss, S Huber, I von Luettichau, PJ Nelson, HC Ott, KW Jauch, CJ Bruns. (2009). Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype, enhance lymphatic regeneration in vivo. Circulation 119:281-289
45. Zhou H, M Wang, C Hou, X Jin, X Wu. (2011). Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema. Jpn J Clin Oncol 41:841-846